The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Hosted on MSN7h
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
Labroots6d
FDA approval of new drug for hormone positive breast cancer
On January 17, 2025, the Food and Drug Administration (FDA ... This approval marks a significant advancement in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor ...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Trump Administration Delays Funding To Cancer Research
A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...
MedCity News6d
AstraZeneca, Daiichi Sankyo ADC Lands FDA Approval in Advanced Breast Cancer
The company is also seeking to expand use of the drug to other cancers. Last week, the FDA accepted an application seeking approval of the ADC for EGFR-mutated non-small cell lung cancer.
Healio5d
FDA approves Datroway for advanced breast cancer
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer. The agent improved ... is a Trop-2-directed antibody-drug conjugate.
Morningstar6d
Daiichi Sankyo Shares Jump After U.S. FDA Approves Breast Cancer Drug
The Japanese government approved the breast cancer drug in late December. Jefferies analysts said in a note that they had assumed a 65% chance of FDA approval, but they believe that the market was ...
MarketWatch11d
J&J Initiates Bid for FDA Approval of TAR-200 in Bladder Cancer
Johnson & Johnson has initiated an application seeking Food and Drug Administration approval of its TAR-200 drug-device combination for the treatment of certain patients with bladder cancer.
Cure Today10d
FDA Approves Lumakras with Vectibix in KRAS G12C+ Colorectal Cancer
The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy. The Food and Drug Administration (FDA) has approved Lumakras ...
JD Supra1d
FDA Bans Red Dye No. 3 Under the Delaney Clause
The US Food and Drug Administration (FDA) has revoked its authorization for the use of FD&C Red No. 3, also known as Red Dye No. 3. Issued on ...
Reuters9d
US FDA approves AstraZeneca's drug for breast cancer
Jan 17 (Reuters) - The U.S. Food and Drug Administration has ... Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions.